Coloplast A/S (CBHD) Stock Statistics & Valuation Metrics

Coloplast A/S has a market cap or net worth of CHF20.57B. The enterprise value is CHF195.98B.

Coloplast A/S has 210,200,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Coloplast A/S’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 13.38%.

The current PE Ratio of Coloplast A/S is 38.95. Coloplast A/S’s PEG ratio is 34.61.

In the last 12 months, Coloplast A/S had revenue of 27.03B and earned 5.05B in profits. Earnings per share was 22.46.

In the last 12 months, operating cash flow was 2.98B and capital expenditures -1.33B, giving a free cash flow of 1.66B billion.

Coloplast A/S pays an annual dividend of CHF2.773, resulting in a dividend yield of 3.02%

Coloplast A/S upcoming earnings date is May 6, 2025, TBA Not Confirmed.

Coloplast A/S as a current ratio of 1.02, with Debt / Equity ratio of 160.13%

In the past 12 months, Coloplast A/S has paid 1.34B in taxes.

Coloplast A/S EV to EBITDA ratio is 25.52, with an EV/FCF ratio of 136.64.

Coloplast A/S has CHF906.00M in cash and marketable securities with kr24.76B in debt, giving a net cash position of CHF23.85B billion.

Gross margin is 67.45%, with operating margin of 27.08%, and net profit margin of 18.69%.

The average price target for Coloplast A/S is CHF109.39, which is 11.43% higher than the current price. The consensus rating is Moderate Buy